Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 11.12.2024Mylan Ireland Limited (MNY)0740BMetformin Mylan XR 1000 mg (tbl plg 60x1000 mg (blis.Al/PVC))30.4.2025Z
 11.12.2024B.Braun Melsungen AG (BME)76566Metronidazol B. Braun 5 mg/ml (sol inf 20x100 ml/500 mg (fľ. PE))11.12.2024R
 11.12.2024ratiopharm GmbH (RAT)38786Trandolapril-ratiopharm 2 mg (cps dur 98x2 mg)10.12.2024O
 11.12.2024SIAD Slovakia spol. s r.o. (SDK-1)9204DOxid uhličitý medicinálny SIAD (gas mlf 1x10 l (fľ.oceľová s štandard.ventil.))11.12.2024U
 11.12.2024SIAD Slovakia spol. s r.o. (SDK-1)9212DOxid uhličitý medicinálny SIAD (gas mlf 1x40 l (fľ.oceľová s štandard.ventil.))11.12.2024U
 10.12.2024Berlin-Chemie AG (BCE)59166Espumisan L (gte por 1x30 ml (fľ.skl.jantárová))23.10.2024O
 10.12.2024B.Braun Melsungen AG (BME)49679Propofol-Lipuro 1 % (10 mg/ml) (emu ijf 10x50 ml/500 mg (liek.skl.))10.12.2024O
 10.12.2024Zentiva, k.s. (ZNT-1)9613DJazeta 100 mg (tbl flm 28x100 mg (blis.PVC/PVDC/Al))31.3.2025Z
 10.12.2024Zentiva, k.s. (ZNT-1)9615DJazeta 100 mg (tbl flm 56x100 mg (blis.PVC/PVDC/Al))28.2.2025Z
 10.12.2024Zentiva, k.s. (ZNT-1)9618DJazeta 50 mg (tbl flm 28x50 mg (blis.PVC/PVDC/Al))31.5.2025Z
 10.12.2024Zentiva, k.s. (ZNT-1)0860EJamesi 50 mg/850 mg (tbl flm 196x50 mg/850 mg (blis.PVC/PVDC/Al))11.12.2024O
 10.12.2024Zentiva, k.s. (ZNT-1)8687DEzen 10 mg (tbl 90x10 mg (blis.PVC/PE/PVDC/Al))11.12.2024O
 10.12.2024Zentiva, k.s. (ZNT-1)04178Triamcinolon E Léčiva (ung der 1x20 g (tuba Al))10.12.2024R
 10.12.2024Zentiva, k.s. (ZNT-1)2516DZetovar 10 mg/80 mg tablety (tbl 30x10 mg/80 mg (blis.OPA/Al/PVC))10.12.2024R
 10.12.2024Zentiva, k.s. (ZNT-1)35912Celaskon long effect (cps pld 30x500 mg (blis. PVC/PVDC))10.12.2024R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)